CARE revises Parabolic Drugs rating; stock up

MUMBAI: CARE has revised the credit ratings of Parabolic Drugs to CARE BBB- (Triple B minus) and PR3 in December 2010 from CARE BB (Double B) and PR4 in December 2009.

The stock was at Rs 42.85, up 0.23 per cent on the BSE. It touched a high of Rs 43 and low of Rs 42.30 in trade so far. CARE revises Parabolic Drugs rating;stk up